A Phase I Study of 5-Fluorouracil/Leucovorin and Arsenic Trioxide for Patients with Refractory/Relapsed Colorectal Carcinoma

This Phase I study was designed to determine a safe combination dose of 5-fluorouracil (5-FU) and arsenic trioxide (ATO) to treat 5-FU-resistant relapsed/refractory colorectal cancer patients. We studied the effect of ATO in the downregulation of thymidylate synthase (TS) in peripheral blood mononuc...

Full description

Saved in:
Bibliographic Details
Published in:Clinical cancer research Vol. 16; no. 11; pp. 3019 - 3027
Main Authors: ARDALAN, Bach, SUBBARAYAN, Pochi R, LIMA, Mayra, GANJEI-AZAR, Parvin, RAMOS, Yipsel, GONZALEZ, Michael, FERNANDEZ, Anthony, MEZENTSEV, Dmitry, REIS, Isildinha, DUNCAN, Robert, PODOLSKY, Lisa, LEE, Kelvin
Format: Journal Article
Language:English
Published: Philadelphia, PA American Association for Cancer Research 01-06-2010
Subjects:
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Be the first to leave a comment!
You must be logged in first